Global & US Gene Therapy Market Forecast to 2020 – Gene Therapy for Hemophilia B Offers Significant Opportunity – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
& US Gene Therapy Market Forecast to 2020”
report has been
added to ResearchAndMarkets.com’s offering.

Gene therapy is one of the most widely researched fields in the
healthcare industry. The high potential of gene therapy to cure various
chronic diseases makes it a popular research area. Various researches
are being performed across the globe to explore the potential of gene
therapy for the treatment of incurable diseases, such as diabetes,
cancer, and HIV amongst others.
The major part of the revenue of gene therapy market is generated from
research phase. Most of the gene therapy products are in research
phases, only few products have been commercialized till date. The report
also provides the sales of major marketed gene therapy products, and the
list of the products in clinical/pre-clinical research along with their
clinical phases.
North America continues to have the maximum number of clinical trials in
the gene therapy segment. This is a major reason for the dominant
position of North America in the gene therapy market.

Market Dynamics

Drivers

  • Failure of Conventional Therapies to Treat Cancers
  • Rising Focus to Accelerate Commercialization of Gene Therapy in
    Developed Nations
  • Rising Incidence of Chronic and Life-Threatening Diseases
  • Growing Interest of Venture Capital Firms

Restraints

  • Stringent Regulatory Laws & Safety Concerns
  • Challenges in Commercialization of Gene Therapy
  • High Cost of the Gene Therapy Drugs
  • Pitfalls in Current Technique
  • Production & Manufacturing: A Unique Challenge for Gene Therapies

Opportunities

  • Approval of Gene Therapy Drug in Europe
  • Gene Therapy for Hemophilia B Offers Significant Opportunity

Industry Trends

  • Gene Silencing: Gaining Momentum
  • Advanced Therapies: Combining Gene Therapy and Stem Cell Technology
  • Immunodeficiency Syndromes: The Focus of Gene Therapy
  • Nanotechnology: Empowering Gene Therapy
  • Gene Therapy: A New Hope to Treat Blindness
  • Gene Therapy: Potential Cure for Cancer

Winning Imperatives

  • Investment in R&D Activities

Key Topics Covered

1. Analyst View

2. Research Methodology

3. Gene Therapy – An Introduction

4. Industry Overview

5. Clinical Trial Assessment & Pipeline Analysis

6. Gene Therapy Market – Regulatory Landscape & Reimbursement Scenario

7. Marketed Gene Therapies

8. Gene Therapy Market

9. Gene Therapy Market by Application

10. Gene Therapy Market Size by Geography

11. Competitive Landscape

12. Key Players Analysis

  • Spark Therapeutics LLC
  • ViroMed Co. Ltd. dba VM BioPharma
  • Advantagene Inc.
  • Bluebird Bio
  • Sanofi
  • Vical Inc.
  • Oxford BioMedica PLC
  • Genethon
  • uniQure N.V.
  • Human Stem Cells Institute
  • Shanghai Sunway Biotech Co. Ltd.
  • Sibiono GeneTech Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/62xvm7/global_and_us?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.